Sonap Forte Caplet 550mg

País: Malasia

Idioma: inglés

Fuente: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Ingredientes activos:

NAPROXEN SODIUM

Disponible desde:

IMEKS PHARMA SDN. BHD.

Designación común internacional (DCI):

NAPROXEN SODIUM

Unidades en paquete:

100 Tablet Tablets; 50 Tablet Tablets; 500 Tablet Tablets

Fabricado por:

Sriprasit Pharma Co. Ltd.

Información para el usuario

_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
SONAP CAPLET / FORTE CAPLET
Naproxen sodium (275mg, 550mg)
_ _
1
WHAT IS IN THIS LEAFLET
1.
What Sonap/Sonap Forte is used for
2.
How Sonap/Sonap Forte works
3.
Before you use Sonap/Sonap Forte
4.
How to use Sonap/Sonap Forte
5.
While you are using it
6.
Side Effects
7.
Storage
and
Disposal
of
Sonap/Sonap
Forte
8.
Product Description
9.
Manufacturer and Product Registration
Holder
10.
Date of Revision
WHAT SONAP/SONAP FORTE IS USED FOR
Sonap/Sonap
Forte
contains
the
active
ingredient naproxen sodium.
Sonap/Sonap Forte is used:
• To treat signs and symptoms of acute gout,
dysmenorrhoea
(period
pain),
menorrhagia
(heavy
and
prolonged
menstrual
period),
headache, acute migraine attack.
• To treat signs and symptoms of mild to
moderately
severe,
acute
or
chronic
musculoskeletal
and
soft
tissue
inflammation.
• To relief mild and moderate pain including
pain after giving birth, pain following IUD
insertion (contraceptive coil fitted), pain after
operation
and
pain
due
to
orthopaedic
surgery.
HOW SONAP/SONAP FORTE WORKS
Naproxen sodium belongs to the group of
medicines
called
non-steroidal
anti-
inflammatory drug (NSAIDs). It works to
reduce pain and inflammation (swelling and
redness) by inhibiting the activity of certain
hormones.
BEFORE YOU USE SONAP/SONAP FORTE_ _
-
_When you must not use it_
• Have ever had a reaction or been told that
you are allergic to naproxen sodium or to any
of the excipients.
•If
you
have
had
asthma,
rhinitis
(inflammation
of
the
nasal
mucous
membrane), urticaria (itching or hives) and
the
symptoms
become
worsen
caused
by
Aspirin or NSAIDs.
• If you have or have had stomach ulcer or
intestinal inflammatory disease.
-
_Before you start to use it _
Tell your doctor if you:
•
Have
allergies
to
any
other
medicines,
food, preservatives or dyes.
• Have heart problems, high blood pressure
and previous stroke.
• Have impaired kidney and liver functions.
• Have blood cells disorder.
• Sonap/Sonap Forte may cause severe skin
react

Ficha técnica

SONAP
275
MG & SONAP FORTE
550
MG CAPLET
Patients with uncontrolled hypertension, congestive heart failure,
established ischemic
heart disease, peripheral arterial disease, and/or cerebrovascular
disease should only be
treated with naproxen after careful consideration and the lowest
effective dose should be
used for the shortest possible duration. Similar consideration should
be made before
initiating longer-term treatment of patients with risk factors for
cardiovascular disease (e.g.
hypertension, hyperlipidemia, diabetes mellitus, smoking).
Gastrointestinal ulceration, bleeding and perforation
GI bleeding, ulceration or perforation, which can be fatal, has been
reported with all NSAIDs
at any time during treatment, with or without warning symptoms or a
previous history of
serious GI events. The risk of GI bleeding, ulceration or perforation
is higher with increasing
NSAID doses, in patients with a history of ulcer (particularly if
complicated with haemorrhage
or perforation), in elderly, alcoholism and smoking patients.
These patients should commence treatment on the lowest dose available.
Combination
therapy with protective agents (e.g. misoprostol or proton pump
inhibitors) should be
considered for these patients, and also for patients requiring
concomitant low dose aspirin,
or other drugs likely to increase gastrointestinal risk.
Patients with a history of GI toxicity, particularly the elderly,
should report any unusual
abdominal symptoms (especially GI bleeding) particularly in the
initial stages of treatment.
Caution should be advised in patients receiving concomitant
medications which could
increase risk of ulceration or bleeding, such as oral corticosteroids,
anticoagulants such
as warfarin, selective serotonin-reuptake inhibitors or anti-platelet
agents such as aspirin.
When GI bleeding or ulceration occurs in patients receiving naproxen,
the treatment
should be withdrawn.
NSAIDs should be given with care to patients with a history of
gastrointestinal disease
(ulcerative colitis, Crohn’s disease) as t